Diabetes Mellitus : Delivery is not the end of the story Molar pregnancy examined Expert panel advises VBAC guideline reassessment SMFM meeting highlights
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More